The global prevalence of hypertensive heart disease continues to rise, particularly in high socio-demographic index regions, highlighting the need for tailored regional strategies.
Despite the global decline in the ASR of DALYs for HHD, the prevalence ASR continues to increase, particularly in high SDI regions. Tailored strategies based on regional and national heterogeneity are required to reduce the global HHD burden.
Liu et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: